1. Home
  2. MOGO vs NNVC Comparison

MOGO vs NNVC Comparison

Compare MOGO & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.11

Market Cap

27.6M

Sector

N/A

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.23

Market Cap

24.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
NNVC
Founded
2003
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
24.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MOGO
NNVC
Price
$1.11
$1.23
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
113.3K
350.2K
Earning Date
11-07-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
N/A
Revenue This Year
$63.05
N/A
Revenue Next Year
$5.58
N/A
P/E Ratio
$4.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.94
52 Week High
$3.83
$2.23

Technical Indicators

Market Signals
Indicator
MOGO
NNVC
Relative Strength Index (RSI) 34.67 43.55
Support Level $1.09 $1.23
Resistance Level $1.16 $1.39
Average True Range (ATR) 0.05 0.11
MACD 0.01 0.01
Stochastic Oscillator 12.47 34.29

Price Performance

Historical Comparison
MOGO
NNVC

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: